Zobrazeno 1 - 10
of 100
pro vyhledávání: '"M B Fennerty"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:146-165
Aliment Pharmacol Ther 2011; 34: 146–165 Summary Background Factors other than acid may play a role in gastro-oesophageal reflux disease (GERD) and its complications. Aim To assessed the role of bile acids in the pathogenesis of GERD, Barrett’s o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6df8ed0888f2e15da6dace7e0c647a6
https://doi.org/10.1111/j.1365-2036.2011.04709.x
https://doi.org/10.1111/j.1365-2036.2011.04709.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:33-40
Aliment Pharmacol Ther 2011; 33: 33–40 Summary Background MiraLAX is gaining acceptance as a bowel cleanser for colonoscopy. We hypothesize that MiraLAX/Gatorade is as efficacious for bowel cleansing as Golytely and is more tolerable for patients u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92d0fb90db71f357aa43daf77237a57c
https://doi.org/10.1111/j.1365-2036.2010.04493.x
https://doi.org/10.1111/j.1365-2036.2010.04493.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 30:459-468
Summary Background Frequent nighttime heartburn is common. Lansoprazole 15 mg is indicated for treatment of heartburn and other gastro-oesophageal reflux disease-related symptoms. Aim To evaluate the efficacy and safety of lansoprazole in self-treati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93e2ff8facdeb1b7b53403e1242af66
https://doi.org/10.1111/j.1365-2036.2009.04064.x
https://doi.org/10.1111/j.1365-2036.2009.04064.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 25:1423-1427
Summary Background Helicobacter pylori infection is a major cause of peptic ulcer disease, but the prevalence of this infection has been decreasing steadily. Additionally, eradication of H. pylori decreases ulcer recurrence and prevents ulcer complic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb70f0a62b21ed473ec29e96d4f2be0b
https://doi.org/10.1111/j.1365-2036.2007.03340.x
https://doi.org/10.1111/j.1365-2036.2007.03340.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 7:339-345
SUMMARY Barrett's oesophagus is receiving increasing scrutiny as the rates of adenocarcinoma of the oesophagus rise. Because clinical features are not predictive of the presence of Barrett's oesophagus and most individuals with Barrett's oesophagus g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d7a623babf5a9974fa7b529bb9d86bc
https://doi.org/10.1111/j.1365-2036.1993.tb00107.x
https://doi.org/10.1111/j.1365-2036.1993.tb00107.x
Autor:
M. B. Fennerty
Publikováno v:
Alimentary Pharmacology and Therapeutics. 22:39-44
Although proton-pump inhibitors are highly effective for the treatment of gastro-oesophageal reflux disease, there are issues with long-term maintenance therapy: not all patients require full daily dose for maintenance treatment, some patients are re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7f91bf62553462f506da50f766cf0e
https://doi.org/10.1111/j.1365-2036.2005.02711.x
https://doi.org/10.1111/j.1365-2036.2005.02711.x
Publikováno v:
Alimentary Pharmacology and Therapeutics. 21:455-463
Summary Background : Secondary analyses from previous studies indicated that esomeprazole was more effective than lansoprazole and omeprazole in healing moderate or severe (Los Angeles grades C or D) erosive oesophagitis (EE). Aim : To compare prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77310db036e867182df580e48a2a2155
https://doi.org/10.1111/j.1365-2036.2005.02339.x
https://doi.org/10.1111/j.1365-2036.2005.02339.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:1241-1251
Summary Background : Proton-pump inhibitors are often recommended for continuous use in gastro-oesophageal reflux disease, but this may not be necessary in all patients. Aim : To ascertain the level of evidence for alternative strategies for proton-p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::297b0ad0c7228f7fd8bf6e205ad38518
https://doi.org/10.1111/j.1365-2036.2004.02289.x
https://doi.org/10.1111/j.1365-2036.2004.02289.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 18:1083-1089
Summary Background : Available prospectively acquired data on the distribution of oesophageal motor abnormalities in patients being evaluated for non-cardiac chest pain and/or dysphagia are relatively scarce. Aim : To evaluate the distribution of oes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d074a73ad9af46bb2c709cf5f815bf50
https://doi.org/10.1046/j.1365-2036.2003.01772.x
https://doi.org/10.1046/j.1365-2036.2003.01772.x